Recent And Upcoming FDA Advisory Committee Meetings

Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.

Topics	Advisory Committee	Date	Details
Overview and updates of research programs in the Tumor Vaccines and Biotechnology Branch and Cellular and Tissue Therapy Branch, Division of Cellular and Gene Therapies, Office of Tissues and Advanced Therapies in CBER	Cellular, Tissue and Gene Therapies	May 8 (teleconference)	Meeting notice (Also see "Virtual Advisory Committees Pose Technical And Practical Challenges For US FDA, Sponsors" - Pink Sheet, 18 May, 2020.)
Pediatric development plans for Salarius Pharmaceuticals' SP 2577 and Celgene's (Bristol-Myers Squibb) marizomib	Oncologic Drugs Pediatric Subcommittee	June 17 (teleconference)	Meeting notice (Also see "US FDA Oncology AdComm's Pediatric Study Reviews Go Virtual" - Pink Sheet, 3 Jun, 2020.)
Pediatric development plans for Tessa Therapeutics' CD30 CAR-T and Syndax Pharmaceuticals' SNDX-5613	Oncologic Drugs Pediatric Subcommittee	June 18 (teleconference)	Meeting notice (Also see "US FDA Oncology AdComm's Pediatric Study Reviews Go Virtual" - Pink Sheet, 3 Jun, 2020.)